2m 2m 2m 2m 2m 2m 2m
CITIUS ONCO (CTOR)
NASDAQ
$0.69+$0.03 (+4.55%)
Price as of Jun 25, 2026 7:34 PM EDT- $63.7MMarket Cap
- -81.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CITIUS ONCO (CTOR)
$0.69+$0.03 (+4.55%)
CTOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.66 | ||
Change | -$0.03 (-3.72%) | ||
Open | $0.71 | ||
High | $0.72 | ||
Low | $0.66 | ||
Previous Close | $0.69 | ||
Volume | 32,328 | ||
30-Day Average Volume | 63,372 | ||
1-Week Change | -1.45% | ||
1-Month Change | -21.42% | ||
1-Year Change | -81.14% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 93.0M | ||
Total Assets | $100.7M | ||
Market Cap | $63.7M | ||
Enterprise Value | $61.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$26.6M | ||
Free Cash Flow | -$3.8M | ||
EBIT | -$26.8M | ||
EBITDA | -$26.8M | ||
Net Working Capital | -$29.4M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue